Injunction Expands Abbott’s Block On 'Gray Market' Test Strips
This article was originally published in The Gray Sheet
The device firm is pursuing a trademark infringement case against multiple distributors for selling diabetes test strips intended for international use in the US. Some of the distributors fought Abbott’s request for an injunction against them by arguing that the international strips posed no harm to domestic patients, but a District Court disagreed and granted the injunction.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.